Dr. Dahlberg received her PhD in biostatistics from Harvard University in 2005, and joined the Department of Biostatistics & Computational Biology at Dana-Farber Cancer Institute in 2006. Her collaborative work focuses primarily in lung cancer with investigators in the Thoracic Oncology Program at DFCI and as the primary statistician for the Eastern Cooperative Oncology Group's Thoracic Committee. Her independent research is in the areas of masked cause failure time data, clinical trial design, and novel analyses of lung cancer data, with a particular interest in comorbidities of lung cancer patients.